Association of Genetic Variants of MTHFR, ENPP1, and ADIPOQ with Myocardial Infarction in Egyptian Patients

[1]  H. Benrahma,et al.  Association of the C677T polymorphism in the human methylenetetrahydrofolate reductase (MTHFR) gene with the genetic predisposition for type 2 diabetes mellitus in a Moroccan population. , 2012, Genetic testing and molecular biomarkers.

[2]  H. Schinzel,et al.  Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase , 2011, Phlebology.

[3]  Q. Hasan,et al.  Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications. , 2011, Genetic testing and molecular biomarkers.

[4]  Shumin Deng,et al.  Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population , 2011, Molecular Biology Reports.

[5]  L. Salazar,et al.  Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects. , 2010, Genetic testing and molecular biomarkers.

[6]  Xue-jian Hu,et al.  C-reactive protein, vitamin B12 and C677T polymorphism of N-5,10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population. , 2010, Clinical and investigative medicine. Medecine clinique et experimentale.

[7]  M. Marre,et al.  Adiponectin Multimers and ADIPOQ T45G in Coronary Artery Disease in Caribbean Type 2 Diabetic Subjects of African Descent , 2010, Obesity.

[8]  In-kyu Lee,et al.  Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. , 2010, Diabetes research and clinical practice.

[9]  C. Leitão,et al.  [ENPP1 K121Q polymorphism and ischemic heart disease in diabetic patients]. , 2010, Arquivos brasileiros de cardiologia.

[10]  M. Abid,et al.  Relationship between genetic polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase as risk factors for type 2 diabetes in Tunisian patients. , 2010, Clinical biochemistry.

[11]  F. Perticone,et al.  ENPP1 Q121 Variant, Increased Pulse Pressure and Reduced Insulin Signaling, and Nitric Oxide Synthase Activity in Endothelial Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[12]  A. Minenna,et al.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  F. Pellegrini,et al.  Role of the ENPP1 K121Q Polymorphism in Glucose Homeostasis , 2008, Diabetes.

[14]  T. Mueller,et al.  The K121Q polymorphism of ENPP1 and peripheral arterial disease , 2008, Heart and Vessels.

[15]  E. Kang,et al.  Adiponectin gene polymorphism 45T>G is associated with carotid artery plaques in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[16]  Xiaochun Kang,et al.  ASSOCIATIONS BETWEEN 45T/G POLYMORPHISM OF THE ADIPONECTIN GENE AND PLASMA ADIPONECTIN LEVELS WITH TYPE 2 DIABETES , 2007, Clinical and experimental pharmacology & physiology.

[17]  M. Yamagishi,et al.  Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. , 2007, Journal of atherosclerosis and thrombosis.

[18]  T. Hansen,et al.  Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects , 2006, Diabetologia.

[19]  A. Doria,et al.  The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. , 2005, Diabetes.

[20]  R. Clarke,et al.  Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies , 2005, Journal of thrombosis and haemostasis : JTH.

[21]  C. Dina,et al.  The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non‐insulin‐dependent) diabetes mellitus , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[22]  S. Hadjadj,et al.  Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. , 2004, Diabetes.

[23]  R. Terkeltaub,et al.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification , 2003, Nature Genetics.

[24]  H. Markus,et al.  Early Carotid Atherosclerosis and Family History of Vascular Disease: Specific Effects on Arterial Sites Have Implications for Genetic Studies , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[25]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.

[26]  P. Cugini,et al.  Higher blood pressure load (baric impact) in normotensives with endothelial dysfunction: a paraphysiological status of "pre-hypertension". , 2002, La Clinica terapeutica.

[27]  C. Bogardus,et al.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.

[28]  M. Pfeffer,et al.  Cardiovascular Risk Assessment Using Pulse Pressure in the First National Health and Nutrition Examination Survey (NHANES I) , 2001, Hypertension.

[29]  A. Pizzuti,et al.  The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). , 2001, Diabetes.

[30]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[31]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[32]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Mangge,et al.  Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. , 2000, Diabetes care.

[34]  G Scarlato,et al.  A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. , 1999, Diabetes.

[35]  D. Wilcken,et al.  Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. , 1998, Circulation.

[36]  G. Andrews,et al.  Burden of disease , 1998, British Journal of Psychiatry.

[37]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[38]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[39]  R. Rozen.  Annotation Molecular genetics of methylenetetrahydrofolate reductase deficiency , 1996, Journal of Inherited Metabolic Disease.

[40]  I. Pabinger,et al.  Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[41]  M. Shichiri,et al.  Insulinlike Growth Factor‐I Induces Hypertrophy With Enhanced Expression of Muscle Specific Genes in Cultured Rat Cardiomyocytes , 1993, Circulation.

[42]  M. Norusis,et al.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.

[43]  W. Garvey,et al.  Adiponectin multimeric complexes and the metabolic syndrome trait cluster. , 2006, Diabetes.

[44]  Fu-Mei Chung,et al.  ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. , 2006, The review of diabetic studies : RDS.

[45]  I. Goldfine,et al.  Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. , 2000, Diabetes.

[46]  B. Maddux,et al.  Membrane Glycoprotein PC1 Inhibition of Insulin Receptor Function Occurs Via Direct Interaction With the Receptor-Subunit , 1999 .

[47]  R. Rozen.  Molecular genetics of methylenetetrahydrofolate reductase deficiency. , 1996, Journal of inherited metabolic disease.

[48]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[49]  Diabetes mellitus. Report of a WHO Study Group. , 1985, World Health Organization technical report series.

[50]  Patrick Murphy,et al.  What Is Statistics , 2014 .